Literature DB >> 2189589

Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.

N Chiannilkulchai1, N Ammoury, B Caillou, J P Devissaguet, P Couvreur.   

Abstract

In our previous studies, doxorubicin-loaded polyisohexylcyanoacrylate nanoparticles have been proven to increase dramatically the antitumoral activity of the cytotoxic agent in metastasis-bearing mice. The experimental model consisted of metastases induced by i.v. inoculation of reticulosarcoma M 5076 cell suspension to C57BL/6 mice. The improved efficacy of the drug was noted in terms of either metastasis count or survival. Therefore, tissue-distribution studies of this drug delivery system within the metastatic liver after i.v. administration were undertaken to gain more insight into the mechanism of action. Doxorubicin measurements in healthy hepatic or neoplastic tissue were carried out together with histological examinations using transmission electron microscopy. These results demonstrated the hepatic tissue to be an efficient reservoir of the drug when it was injected associated with nanoparticles. Accumulation of biodegradable nanoparticles with associated doxorubicin in Kupffer cells created a gradient of drug concentration for a massive and prolonged diffusion of the free drug towards the neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189589     DOI: 10.1007/bf02897257

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.

Authors:  J Lautersztain; R Perez-Soler; J Turpin; A R Khokhar; Z H Siddik; K Schmidt; G Lopez-Berestein
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

Review 2.  Liposomes as drug carriers in cancer chemotherapy.

Authors:  J N Weinstein; L D Leserman
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

3.  A murine ovarian tumor with unique metastasizing capacity.

Authors:  G Alessandri; R Giavazzi; P Falautano; F Spreafico; S Garattini; A Mantovani
Journal:  Eur J Cancer       Date:  1981-06       Impact factor: 9.162

4.  Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.

Authors:  A Gabizon; A Dagan; D Goren; Y Barenholz; Z Fuks
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

5.  Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.

Authors:  P Couvreur; B Kante; L Grislain; M Roland; P Speiser
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

6.  Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.

Authors:  R L Juliano; D Stamp
Journal:  Biochem Pharmacol       Date:  1978-01-01       Impact factor: 5.858

7.  Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma.

Authors:  R Perez-Soler; A R Khokhar; J Lautersztain; P A Mitchell; K L Schmidt
Journal:  Cancer Drug Deliv       Date:  1987

8.  Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin.

Authors:  E Mayhew; Y Rustum; W J Vail
Journal:  Cancer Drug Deliv       Date:  1983

9.  Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.

Authors:  Q G van Hoesel; P A Steerenberg; D J Crommelin; A van Dijk; W van Oort; S Klein; J M Douze; D J de Wildt; F C Hillen
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

10.  Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.

Authors:  J E Talmadge; M E Key; I R Hart
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

View more
  21 in total

Review 1.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

2.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

3.  Microcalorimetric method to assess phagocytosis: macrophage-nanoparticle interactions.

Authors:  M H D Kamal Al-Hallak; Muhammad Khan Sarfraz; Shirzad Azarmi; M H Gilzad Kohan; Wilson H Roa; Raimar Löbenberg
Journal:  AAPS J       Date:  2010-11-06       Impact factor: 4.009

4.  Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

Authors:  C E Soma; C Dubernet; G Barratt; F Nemati; M Appel; S Benita; P Couvreur
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.

Authors:  G Schwab; C Chavany; I Duroux; G Goubin; J Lebeau; C Hélène; T Saison-Behmoaras
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

Authors:  A E Gulyaev; S E Gelperina; I N Skidan; A S Antropov; G Y Kivman; J Kreuter
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

7.  Body distribution of nanoparticle-containing adriamycin injected into the hepatic artery of hepatoma-bearing rats.

Authors:  Jiang-Hao Chen; Ling Wang; Rui Ling; Yu Li; Zhe Wang; Qing Yao; Zhong Ma
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit.

Authors:  F Fawaz; F Bonini; M Guyot; A M Lagueny; H Fessi; J P Devissaguet
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

9.  Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro.

Authors:  L Manil; J C Davin; C Duchenne; C Kubiak; J Foidart; P Couvreur; P Mahieu
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

10.  Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery.

Authors:  Jiang-Hao Chen; Rui Ling; Qing Yao; Ling Wang; Zhong Ma; Yu Li; Zhe Wang; Hu Xu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.